The DB Group’s recent work on “Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy” was featured on the cover page of Nano Letters. Congratulations to former postdoctoral fellow Dr. Matthias Oberli and Professor Daniel Blankschtein!